CureVac N.V. earned $0.75 per diluted share in fiscal year 2024. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2024 through Q2 FY2025, the same line adds up to $0.97 per diluted share. The table below carries 7 fiscal years, from 2018 to 2024, and the quarters CureVac N.V. has filed alongside them.
FY2024 annual
EPS (Diluted)$0.75
YoYn/m
5Y CAGRn/m
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2025, ended Jun 30, 2025ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
CVAC EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was CureVac N.V.'s diluted earnings per share in fiscal year 2024?
CureVac N.V. earned $0.75 per diluted share in fiscal year 2024.
How fast is CureVac N.V.'s diluted earnings per share growing?
CureVac N.V. (CVAC) reported a loss of $1.31 per diluted share in fiscal year 2023 and $0.75 per diluted share in fiscal year 2024. A growth rate is not meaningful here, because the earlier figure was zero or negative.
What is CureVac N.V.'s diluted earnings per share over the last twelve months?
CureVac N.V. (CVAC) reported $0.97 per diluted share over the trailing 12 months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.
What was CureVac N.V.'s diluted earnings per share in the most recent quarter?
CureVac N.V. (CVAC) reported -$0.31 in diluted earnings per share in Q2 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what CureVac N.V. (CVAC) reported on that line in every period on record.
